Cube - I like your optimism and hope you prove to be right. I have topped up significantly while the price has been at these low levels and stand to retire if your projections (£1 a share) prove to be correct. I still would be interested to know in which area you are expecting news in the next few days. I am familiar with all the team and the areas in which there could be news but you seem fairly certain that at least one of these areas is about to see a positive update.
If you are right then there has been progress from the city presentation a couple of weeks ago which is on the website. The Directors bought at the recent issue but other than Peter Garrod they did not buy the sort of quantities that indicated huge news round the corner although I suppose they still have their various warrants to take up in the event of a lift off.
Big news as I see it could be
-The signing of a nutra license combined with successful GMP/ tox tests
-Commencement of Zolpidem trials perhaps with a signing on fee from a partner
-Progress on the Ad or Parkinsons pharmas perhaps bringing forward trials or partnerships
Other news could be further acquisition or GCPL expansion.
Have I missed anything?
The team has been in place for a while and Peter Garrods joining the board and still buying is very encouraging but that has been the case for some months. So which of these areas do you think / know is about to see positive news?